Lundbeck
HLUN-B.CO
HK$34.96
Share price
0.07%
Change (1 day)
-5.78%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
Earnings for Lundbeck (HLUN-B.CO)
Earnings in 2024 (TTM): HK$4.32 Billion
According to Lundbeck 's latest financial reports the company's current earnings are HK$3.18 Billion. , an increase over its 2023 earnings that were of HK$3.42 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Lundbeck from 2009 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | HK$4.29 B | 25.46% |
| 2023 | HK$3.42 B | 21.69% |
| 2022 | HK$2.81 B | 31.79% |
| 2021 | HK$2.13 B | -4.53% |
| 2020 | HK$2.23 B | -45.08% |
| 2019 | HK$4.07 B | -33.97% |
| 2018 | HK$6.16 B | 12.76% |
| 2017 | HK$5.47 B | 94.32% |
| 2016 | HK$2.81 B | -136.98% |
| 2015 | -HK$7.62 Billion | -1258.1% |
| 2014 | HK$0.65 B | -72.43% |
| 2013 | HK$2.38 B | 4.31% |
| 2012 | HK$2.28 B | -55.26% |
| 2011 | HK$5.10 B | 6.64% |
| 2010 | HK$4.79 B | -6.68% |
| 2009 | HK$5.13 B |